Asset Details
Do you wish to reserve the book?
Benefits and Risks of Third‐Generation Oral Contraceptives
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Benefits and Risks of Third‐Generation Oral Contraceptives
Do you wish to request the book?
Benefits and Risks of Third‐Generation Oral Contraceptives
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Benefits and Risks of Third‐Generation Oral Contraceptives
1999
Overview
OBJECTIVE: To evaluate the risks and benefits of third‐generation oral contraceptives. DATA SOURCES: A medline search was done for English language articles published from 1985 through 1998 relating to the side‐effect profile of third‐generation oral contraceptives or their association with cardiovascular or thromboembolic disease. All articles containing original data were included. DATA SYNTHESIS: The risk of venous thromboembolism appears to be 1.5‐ to 2.7‐fold greater in users of third‐generation, compared with second‐generation, oral contraceptives. Compared with nonusers, women who use third‐generation oral contraceptives may have a 4.8‐ to 9.4‐fold greater risk of venous thromboembolism. Users of third‐generation oral contraceptives do not appear to have an increased risk of myocardial infarction compared with nonusers and may have risk of myocardial infarction of 0.26 to 0.7 compared with second‐generation users. Whether third‐generation oral contraceptives are associated with a decreased stroke risk is still not clear. CONCLUSIONS: Although third‐generation oral contraceptives most likely increase a user's risk of venous thromboembolism, their improved side‐effect profile and their possible decreased association with myocardial infarction and stroke may make them a useful new class of oral contraceptives for most women except those at increased risk of venous thrombosis.
Publisher
Blackwell Science Inc,Springer,Springer Nature B.V
Subject
/ Biological and medical sciences
/ Contraceptives, Oral - adverse effects
/ Drug toxicity and drugs side effects treatment
/ Female
/ Humans
/ Myocardial Infarction - chemically induced
/ Myocardial Infarction - epidemiology
/ Pharmacology. Drug treatments
/ Stroke
/ Venous Thrombosis - chemically induced
/ Venous Thrombosis - epidemiology
/ Veterans
We currently cannot retrieve any items related to this title. Kindly check back at a later time.